Mutant PIK3CA controls DUSP1-dependent ERK 1/2 activity to confer response to AKT target therapy
暂无分享,去创建一个
J. Gschwend | M. Cronauer | R. Nawroth | M. Retz | M. Heck | A. Sathe | M. Thalgott | M. Heck | F. Guerth | Jürgen E. Gschwend
暂无分享,去创建一个
J. Gschwend | M. Cronauer | R. Nawroth | M. Retz | M. Heck | A. Sathe | M. Thalgott | M. Heck | F. Guerth | Jürgen E. Gschwend